Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-20-007965
Filing Date
2020-04-17
Accepted
2020-04-17 16:52:00
Documents
4
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A acrx20191231_10ka.htm 10-K/A 988566
2 EXHIBIT 31.3 ex_181759.htm EX-31.3 4164
3 EXHIBIT 31.4 ex_181760.htm EX-31.4 4162
4 g1.jpg GRAPHIC 56658
  Complete submission text file 0001437749-20-007965.txt   1076010
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35068 | Film No.: 20800308
SIC: 2834 Pharmaceutical Preparations